ResveratrolanimalAnimal model2021

VqBGH40a isolated from Chinese wild Vitis quinquangularis degrades trans-piceid and enhances trans-resveratrol.

Plant science : an international journal of experimental plant biology

confidence

Key findings

VqBGH40a hydrolyzes trans-piceid to trans-resveratrol in vitro and in vivo, enhancing resveratrol content and participating in grapevine defense against powdery mildew.

View source on PubMed (PMID 34315603) ↗

Sample size
Not reported
Population
Chinese wild grapevine Vitis quinquangularis accession Danfeng-2 (plant study)
Dosing
0.1 mM IPTG induction; transient overexpression in leaves
Duration
Not reported
Route
Prokaryotic expression system / transient overexpression in plant leaves
Blinding
not_reported
Controls
none
Drug class
polyphenol
Full abstract

Resveratrol (3,5,4'-trihydroxy-stilbene) is a phytoalexin that can prevent plants from pathogen attacks. Piceid is the glycosylation product of resveratrol and the main storage form of stilbenes in grapevines. Here, we reported the function of a β-glycoside hydrolase gene, VqBGH40a, from the Chinese wild grapevine Vitis quinquangularis accession Danfeng-2 in the regulation of plant resistance to powdery mildew (Uncinula necator). VqBGH40a belonging to β-glycoside hydrolase family 1 encoded 506 amino acids and was located on the cytomembrane. Its optimal induction condition was 28 or 30℃, for 4 h, with 0.1 mM IPTG in a prokaryotic expression system. Enzyme activity detection showed that purified VqBGH40a could hydrolyze trans-piceid to form trans-resveratrol in vitro. VqBGH40a was transiently overexpressed in Danfeng-2 leaves and then artificially inoculated with powdery mildew showed that VqBGH40a protein could hydrolyze trans-piceid in vivo. Additionally, a comparative family analysis between VqBGH40a and 38 VviBGHs was performed. Overall, these results demonstrate that VqBGH40a can hydrolyze trans-piceid, enhance trans-resveratrol content, and participate in the defense mechanism of grapevine against powdery mildew.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.